PeptiDream Inc. (TYO:4587)

Market Cap	133.41B -46.0%
Revenue (ttm)	19.05B -59.2%
Net Income	-3.57B
EPS	-27.63
Shares Out	129.21M
PE Ratio	n/a
Forward PE	10.50
Dividend	n/a
Ex-Dividend Date	n/a

Volume	880,300
Open	1,030.00
Previous Close	1,032.50
Day's Range	1,015.00 - 1,046.00
52-Week Range	1,017.50 - 1,818.50
Beta	0.17
Analysts	Buy
Price Target	2,825.00 (+174.41%)
Earnings Date	May 13, 2026

About PeptiDream

PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug discovery platform that integrates the technologies to synthesize highly diverse macrocyclic peptide libraries and screen for hit compounds, as well as enables rapid and efficient identification of novel hit compounds with high potency and selectivity for protein targets in drug discovery c...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 645
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4587

Analyst Summary

According to 6 analysts, the average rating for 4587 stock is "Buy." The 12-month stock price target is ¥2,825, which is an increase of 174.41% from the latest price.

Price Target

¥2,825

(174.41% upside)

Analyst Consensus: Buy